# Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations

> **NCT02676843** · PHASE2 · COMPLETED · sponsor: **Columbia University** · enrollment: 7 (actual)

## Conditions studied

- Frontotemporal Lobar Degeneration (FTLD)
- Frontotemporal Dementia (FTD)
- Tauopathies

## Interventions

- **DRUG:** 18F-AV-1451

## Key facts

- **NCT ID:** NCT02676843
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2018-11-25
- **Final completion:** 2018-11-25
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2019-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02676843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02676843, "Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02676843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*